本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

窺得兒醫藥

26.81
-1.1300-4.04%
盤後26.810.00000.00%16:10 EDT
成交量:120.46萬
成交額:3,263.21萬
市值:18.20億
市盈率:-3.88
高:28.10
開:27.65
低:26.71
收:27.94
52周最高:49.45
52周最低:22.05
股本:6,790.05萬
流通股本:6,264.90萬
量比:1.16
換手率:1.92%
股息:- -
股息率:- -
每股收益(TTM):-6.9151
每股收益(LYR):-30.5357
淨資產收益率:-15.63%
總資產收益率:1.36%
市淨率:0.65
市盈率(LYR):-0.88

資料載入中...

2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

重要事件披露

Form 8-K - Current report
2024/07/30

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/24

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/29

重要事件披露

Form 8-K - Current report
2024/02/29

重要事件披露

Form 8-K/A - Current report: [Amend]